# Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension

> **NCT05841654** · PHASE4 · UNKNOWN · sponsor: **Beijing Tsinghua Chang Gung Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Hypertension
- Atrial Fibrillation

## Interventions

- **DRUG:** Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI

## Key facts

- **NCT ID:** NCT05841654
- **Lead sponsor:** Beijing Tsinghua Chang Gung Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05841654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05841654, "Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05841654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*